Wardwizard Healthcare Limited returned to profitability in the quarter ended March 31, 2026, reporting a net profit of ₹33.77 lakh compared to a net loss of ₹110.81 lakh in the same period last year. The turnaround was driven by a significant increase in revenue from operations, which surged to ₹57.13 lakh in Q4FY26 from ₹11.29 lakh in Q4FY25. For the full year FY26, the company narrowed its net loss to ₹31.53 lakh from ₹271.33 lakh in FY25, with total income rising to ₹169.70 lakh from ₹41.86 lakh.

The board approved the audited standalone financial results for the fourth quarter and financial year ended March 31, 2026, at a meeting held on May 30, 2026. M/s. Mahesh Udhwani & Associates, Chartered Accountants, audited the results and issued an unmodified opinion, confirming the financial statements give a true and fair view in conformity with applicable Indian accounting standards. The company stated it is not identified as a "Large Corporate" as on March 31, 2026, and reported nil outstanding qualified borrowings.

Financial Performance Summary

Earnings per share (EPS) for continuing operations improved to ₹14.08 in Q4FY26 from a negative ₹45.23 in the prior year quarter. Total assets as of March 31, 2026, stood at ₹103.84 lakh, compared to ₹874.11 lakh in the previous year. The board meeting commenced at 9:00 P.M. and concluded at 10:05 P.M. on May 30, 2026.

Pursuant to Regulation 47 and Regulation 30 of SEBI (LODR) Regulations, 2015, the company intimated the newspaper publication of the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The results were published on June 1, 2026, in the Financial Express (Mumbai and Ahmedabad editions) and Pratahkal (Mumbai edition). The full results are available on the company's website at www.ayokimercantile.com .

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE048E01013/d49ea2d7-a6b2-4296-b3dc-e5ce420509d3.pdf

Wardwizard Healthcare Limited has strengthened its leadership team by appointing Ms. Harshita Kharva as its Chief Financial Officer (CFO), effective May 30, 2026. The decision, approved by the Board based on the recommendations of the Audit Committee and Nomination and Remuneration Committee, designates her as a Key Managerial Personnel (KMP) of the company. This strategic move aims to bolster the company's financial oversight and compliance framework.

Ms. Kharva is a qualified Chartered Accountant holding membership number 641390 with the Institute of Chartered Accountants of India (ICAI). Her appointment follows the disclosure requirements mandated by Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has made the detailed information available on its website and submitted the necessary filings to BSE Limited.

The new CFO brings extensive experience in financial reporting, GST, and income tax matters. Her professional background includes significant work in audit and assurance, having conducted statutory and tax audits for both listed and unlisted entities. She has handled audits for diverse sectors, including pharmaceuticals, chemicals, manufacturing, and multinational corporations involved in turbines and generators.

Professional Background

Ms. Kharva's expertise covers a broad spectrum of financial functions:

• Audit and Assurance: Conducted statutory audits for private limited companies with turnovers exceeding Rs. 100 Crore, alongside tax audits for various firms.
• Direct Taxation: Prepared income computations and filed quarterly TDS returns in compliance with the Income Tax Act.
• Consolidation: Experience in preparing consolidated financial statements for a state government power generation company with six subsidiaries.
• Compliance: Proficient in monitoring statutory compliances related to TDS, GST, PF, PT, and ESIC.

The appointment details were formally communicated to the stock exchange on May 30, 2026. Rajbala Kiroriwal, Company Secretary and Compliance Officer of Wardwizard Healthcare Limited, confirmed the development in the regulatory filing.